Suppr超能文献

通过 SMEDDS 或与 2-羟丙基-β-环糊精复合提高小蓬草中甲氧基黄酮口服传递的新型制剂策略。

Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.

机构信息

Center for Research and Development of Herbal Health Products, Khon Kaen University, Khon Kaen 40002, Thailand.

出版信息

Int J Pharm. 2013 Mar 10;445(1-2):1-11. doi: 10.1016/j.ijpharm.2013.01.052. Epub 2013 Jan 31.

Abstract

The Kaempferia parviflora (KP) plant contains several methoxyflavones including 5,7-dimethoxyflavone (DMF), 5,7,4'-trimethoxyflavone (TMF), and 3,5,7,3',4'-pentamethoxyflavone (PMF). Ethanolic extracts of KP have shown various pharmacological effects and have been used as an aphrodisiac, a antimicrobial agent and for the treatment of inflammation, and peptic ulcers. Given its poor water solubility and low oral bioavailability (1-4%), there are limitations to the utilization of KP. Accordingly, self-microemulsifying drug delivery system (SMEDDS) and cyclodextrin (CD) complex formulations were developed to improve the oral absorption of methoxyflavones. Polyoxyethylene castor oil (53.3%), propylene glycol (26.7%), and triglyceride of coconut oil (20%) were combined to form KP-SMEDDS. A complex of 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD) and KP was prepared by lyophilization. The developed formulations were then evaluated for their physicochemical properties, in vitro dissolution tests, permeability through Caco-2 cells, and in vivo oral absorption in rats by using PMF, TMF, and DMF as the markers for quantitation. The results showed that KP-SMEDDS and KP-2-HP-β-CD complex improved the dissolution rate of methoxyflavones in both 0.1N HCl and 0.2M PBS pH 6.8 compared to KP dissolved in a solution of propylene glycol, PEG 400, ethanol, and water. KP-SMEDDS and KP-2-HP-β-CD formulations showed about 10- and 3.5-fold greater Papp values of methoxyflavones in Caco-2 cells. The oral bioavailability values of KP-SMEDDS formulations were higher than those of KP (25.38-, 42.00-, and 26.01-fold for PMF, TMF, and DMF, respectively). For the KP-2-HP-β-CD complex, oral bioavailability values were 21.63-, 34.20-, and 22.90-fold greater than those of KP, respectively. Therefore, these two novel formulations, KP-SMEDDS and KP-2-HP-β-CD, were successfully developed to improve the dissolution rate, drug permeability through Caco-2 cells and oral bioavailability of methoxyflavones in KP.

摘要

姜黄属植物中含有多种甲氧基黄酮,包括 5,7-二甲氧基黄酮(DMF)、5,7,4'-三甲氧基黄酮(TMF)和 3,5,7,3',4'-五甲氧基黄酮(PMF)。姜黄的乙醇提取物表现出多种药理作用,并被用作春药、抗菌剂以及用于治疗炎症和消化性溃疡。鉴于其较差的水溶性和低口服生物利用度(1-4%),限制了姜黄的利用。因此,开发了自微乳给药系统(SMEDDS)和环糊精(CD)复合物制剂来提高甲氧基黄酮的口服吸收。聚氧乙烯蓖麻油(53.3%)、丙二醇(26.7%)和椰子油的三酸甘油酯(20%)组合形成姜黄-SMEDDS。通过冷冻干燥制备 2-羟丙基-β-环糊精(2-HP-β-CD)和姜黄的复合物。然后,使用 PMF、TMF 和 DMF 作为定量标记物,对开发的制剂进行理化性质、体外溶出度试验、Caco-2 细胞通透性以及大鼠体内口服吸收的评价。结果表明,与溶解在丙二醇、PEG 400、乙醇和水中的姜黄相比,SMEDDS 和 2-HP-β-CD 复合物均能提高甲氧基黄酮在 0.1N HCl 和 0.2M PBS pH6.8 中的溶解速率。SMEDDS 和 2-HP-β-CD 制剂在 Caco-2 细胞中对甲氧基黄酮的 Papp 值约增加了 10 倍和 3.5 倍。SMEDDS 制剂的口服生物利用度值高于姜黄(PMF、TMF 和 DMF 分别为 25.38 倍、42.00 倍和 26.01 倍)。对于 2-HP-β-CD 复合物,口服生物利用度值分别比姜黄高 21.63 倍、34.20 倍和 22.90 倍。因此,成功开发了这两种新型制剂,即姜黄-SMEDDS 和姜黄-2-HP-β-CD,以提高姜黄中甲氧基黄酮的溶解速率、药物透过 Caco-2 细胞的能力和口服生物利用度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验